Dr. Lutz is an associate professor of clinical rehabilitation medicine at Weill Medical College of Cornell University in New York and an attending physician at the Hospital for Special Surgery, also in New York.
Dr. Lutz will be responsible for advancing the company’s brtxDISC program, including preparing the company’s Investigational New Drug/Investigational Device Exemption application with the U.S. Food and Drug Administration.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
